OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

HTML

Year: 2000
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: AIDS
DOI: 10.1097/00002030-200004140-00006
Authors: Joseph J. Eron, Ellen S. Yetzer, Peter J. Ruane, Stephen Becker, Gosford A. Sawyerr, Robin L. Fisher, Jerry M. Tolson, Mark S. Shaefer
Institution: University of North Carolina at Chapel Hill
Language: English

Topic: HIV/AIDS drug development and treatment
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: HIV-1 infection, lamivudine, zidovudine, twice-daily dosing, protease inhibitors, antiretroviral therapy, non-inferiority, virological response, treatment failure, medication adherence, adverse events, antiretroviral-experienced patients, fixed-dose combination, CD4 count, viral load
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2060390219
FWCI: 4.684
Cites: 16
Cited by: 70
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security